Literature DB >> 7905460

Tumor cell vaccination for gynecological tumors.

V Möbus1, S Horn, M Stöck, V Schirrmacher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7905460     DOI: 10.1089/hyb.1993.12.543

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


× No keyword cloud information.
  5 in total

Review 1.  Whole tumor antigen vaccines.

Authors:  Cheryl Lai-Lai Chiang; Fabian Benencia; George Coukos
Journal:  Semin Immunol       Date:  2010-03-30       Impact factor: 11.130

Review 2.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

3.  A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.

Authors:  Lana E Kandalaft; Cheryl L Chiang; Janos Tanyi; Greg Motz; Klara Balint; Rosemarie Mick; George Coukos
Journal:  J Transl Med       Date:  2013-06-18       Impact factor: 5.531

Review 4.  Therapeutic potential of oncolytic Newcastle disease virus: a critical review.

Authors:  Shay Tayeb; Zichria Zakay-Rones; Amos Panet
Journal:  Oncolytic Virother       Date:  2015-03-27

5.  Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion.

Authors:  Noemi García-Romero; Irina Palacín-Aliana; Susana Esteban-Rubio; Rodrigo Madurga; Sergio Rius-Rocabert; Josefa Carrión-Navarro; Jesús Presa; Sara Cuadrado-Castano; Pilar Sánchez-Gómez; Adolfo García-Sastre; Estanislao Nistal-Villan; Angel Ayuso-Sacido
Journal:  Cells       Date:  2020-06-05       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.